James Leighton-Scott, MBA, MBBS

Chief Medical Officer

Professional Overview
James Leighton-Scott is an accomplished pharmaceutical executive with extensive experience in medical and clinical development. As the Chief Medical Officer at Flynn Pharma, he leads the strategic direction and oversight of the company's medical and scientific functions, driving innovation and ensuring the highest standards of patient safety and product efficacy.

Experience Summary

Current Role

As the Chief Medical Officer at Flynn Pharma since 2021, James is responsible for overseeing the medical and clinical aspects of the company's drug development pipeline. He provides strategic leadership in the design and execution of clinical trials, regulatory submissions, and post-marketing surveillance activities. Under his guidance, Flynn Pharma has achieved several key milestones, including the successful completion of a Phase III clinical trial for a novel pain management medication and the expansion of the company's global footprint.

Career Progression

Prior to his current role, James held various senior-level positions at Mundipharma Research Limited, where he progressed from Executive Director of R&D to Senior Vice President of Medical, leading cross-functional teams in the development and commercialization of innovative pharmaceutical products. Earlier in his career, he served as a Senior Medical Advisor in Pharmacovigilance at Napp Pharmaceuticals Limited and as a Clinical Research Physician at LCG Bioscience Limited.

Academic Background
James holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Cambridge and a Master of Business Administration (MBA) from the University of Oxford. His extensive medical training and business acumen have contributed to his strategic leadership and ability to navigate the complex pharmaceutical industry.

Areas of Expertise

• Medical and clinical development

• Regulatory affairs and compliance

• Pharmacovigilance and drug safety

• Strategic planning and decision-making

• Cross-functional team leadership

• Effective stakeholder management

Professional Impact
Throughout his career, James has made significant contributions to the pharmaceutical industry. He has led the successful development and commercialization of multiple drug products, resulting in improved patient outcomes and significant revenue growth for his employers. James is also an active contributor to industry associations and has presented at numerous medical conferences, sharing his expertise and insights with his peers.

Conclusion
With his extensive medical expertise, proven track record of success, and strategic vision, James Leighton-Scott is a valuable asset to Flynn Pharma. As the Chief Medical Officer, he continues to drive the company's growth and innovation, positioning it as a leader in the pharmaceutical industry.